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ABSTRACT: Particulate matter may promote car-
diovascular disease, possibly as a consequence
of its oxidative potential. Studies using suscepti-
ble animals indicate that particulate matter aggra-
vates atherosclerosis by increasing lipid/macrophage
content in plaques. Macrophage lipid uptake requires
oxidized low-density lipoprotein and scavenger re-
ceptors; same receptors are involved in particulate
matter uptake. We studied in vitro particulate mat-
ter potential to oxidize low-density lipoproteins and
subsequent cell uptake through scavenger receptors.
Particulate matter-induced low-density lipoproteins
oxidation was evaluated by the thiobarbituric acid as-
say. Binding/internalization was tested in wild type
and scavenger receptor–transfected Chinese hamster
ovary cells, and in RAW264.7 cells using fluorescently
labeled low-density lipoproteins. Dose-dependent
binding/internalization only occurred in scavenger
receptor–transfected Chinese hamster ovary cells and
RAW264.7 cells. Competition binding/internalization
using particles showed that particulate matter induced
decreased binding (∼50%) and internalization (∼70%)
of particle-oxidized low-density lipoproteins and na-
tive low-density lipoproteins. Results indicate that par-
ticulate matter was capable of oxidizing low-density
lipoproteins, favoring macrophage internalization, and
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also altered scavenger and low-density lipoproteins re-
ceptor function. C© 2012 Wiley Periodicals, Inc. J Biochem
Mol Toxicol 27:69–76, 2013; View this article online at wi-
leyonlinelibrary.com. DOI 10:1002/jbt.21452
KEYWORDS: Particulate Matter; Low-Density Lipopro-
tein; Scavenger Receptor; Macrophages; Oxidative Po-
tential
INTRODUCTION
Exposure to particulate matter (PM) in polluted
cities represents a significant risk to human health [1].
PM is a complex, dynamic mixture of materials with
toxic potential that depends on size and composition
[2, 3]. Several studies have linked cardiovascular mor-
tality and complications of preexisting atherosclerotic
disease after exposure to PM present in polluted air
[4–6].
The mechanisms by which exposure to PM com-
plicates a preexisting cardiovascular condition have
not been fully elucidated yet. However, experimen-
tal studies in humans and animals have provided a
wealth of evidence on how PM exposure can influence
relevant cardiovascular processes including increased
blood pressure, increased blood viscosity, and altered
fibrinogen levels [7]. Arrhythmias, changes in elec-
trocardiographic parameters, and increased vasocon-
striction have been also identified as complications in
elderly subjects [8] and healthy people occupationally
exposed to different types of particles [9, 10]. Subjects
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implanted with defibrillators show an increase in the
frequency of defibrillator interventions and an increase
in the level of serum C-reactive protein in response to
PM exposure [7, 11, 12].
Several studies in humans have also shown a rela-
tionship between carotid intimal-medial thickness and
exposure to PM less than 2.5 μm in aerodynamic di-
ameter (PM2.5), in conjunction with atherosclerosis de-
velopment and coronary artery calcification [13, 14].
Suwa et al. [15] observed advanced coronary artery
and aorta atherosclerotic plaques in Watanabe herita-
ble hyperlipidemic rabbits exposed to PM less than
10 μm in aerodynamic diameter (PM10) compared
to unexposed control animals of the same strain.
Atherosclerotic plaques in exposed animals had a
larger number of cells containing an increased amount
of intracellular lipids, resulting in a greater quantity of
total lipids in aortic lesions. Moreover, Araujo et al. [16]
studied the proatherogenic effects of ultrafine particles
and PM2.5 in genetically susceptible mice (apolipopro-
tein E−/−), which after exposure to PM presented larger
atherosclerotic lesions than control animals. Likewise,
apolipoprotein E−/− mice exposed to PM2.5 showed in-
creased content of lipids, cholesterol, and macrophages
in atherosclerotic plaques, along with a reduced re-
sponse to arterial dilatation. Also apolipoprotein E−/−
mice fed an enriched fat diet exposed to PM presented
an increased development of atherosclerotic plaques in
comparison to animals receiving a balanced diet [17].
Finally, PM causes oxidative stress in cultured cells and
cell-free systems [18–21].
The central objective of our research was to ex-
plore in vitro the capacity of PM to oxidize low-density
lipoprotein (LDL) and to study the possible conse-
quences of PM-induced LDL oxidation in the bind-
ing/internalization of PM-oxidized LDL (PM-ox-LDL)
through the scavenger receptor (SR). SRs are involved
with the development of foam cells by inducing in-
ternalization and accumulation of a large amount of
ox-LDL within macrophages [22]. Since PM is internal-
ized by macrophages through SR [23], the same recep-
tor involved in ox-LDL uptake, we performed several
assays to explore PM-ox-LDL and PM competition for
the same receptor. Finally, to evaluate the effect of PM
on a different group of receptors, we explored PM and




PM2.5 and PM10 were collected in the northern (in-
dustrial) zone of Mexico City, using high-volume sam-
plers (1.13 m3/min) (GMW model 1200, VCF HVPM10;
Sierra Andersen, Smyrna, GA) on nitrocellulose mem-
branes (Sartorius, Goettingen, Germany). Integrated
24-h samples were collected 5 days a week. PM was
recovered from the membranes and handled as previ-
ously reported [24]. The chemical characterization of
samples from the industrial zone of Mexico City has
been reported elsewhere [2, 25].
Low-Density Lipoproteins
Human LDL (density = 1.019-1.063 g/mL) were
isolated from the plasma of three randomly selected
healthy blood bank donors who were in a fasting state
by sequential density ultracentrifugation in potassium
bromide at 4◦C as previously described [26]. The ex-
periments were performed separately on the LDL from
each of the three donors. Lipoproteins were dialyzed
first against 0.15 M NaCl and 0.01% ethylene diamine
tetraacetic acid (EDTA) and then against phosphate
buffered saline (PBS) to eliminate EDTA. LDL concen-
tration is given in terms of its protein content deter-
mined by the bicinchoninic acid method (Pierce, Rock-
ford, IL).
LDL Oxidation by PM2.5 and PM10
Isolated LDL were incubated with increasing
doses of PM2.5 or PM10 (20, 40, and 80 μg/mg LDL)
with and without H2O2 (1 mM) over 24 h at 37◦C, to
evaluate oxidation by the thiobarbituric acid method
(TBA) using a commercially available kit and following
the manufacturer instructions (Northwest, Vancouver,
WA, Canada). This method is based on the reaction of
malondialdehyde with TBA, forming a complex that
absorbs at 532 nm.
The PM dose range used in this study corresponds
to concentration commonly reported in the literature
as having significant in vitro cellular effects. They are
also in a range relevant in magnitude to the exposure
of an average person living in Mexico City at hot spots
on airway bifurcations [27].
LDL Acetylation
Acetylated-LDL (ac-LDL) was prepared by LDL
treatment with acetic anhydride and sodium acetate
[28]. Briefly, an equal volume of saturated solution of
sodium acetate was added to LDL with continuous stir-
ring at a temperature of 4◦C. Then, adequate amount
of acetic anhydride was added to have a total mass of
acetic anhydride equal to 1.5 times the mass of pro-
tein used and incubated for 1 h. Ac-LDL were dialyzed
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against 0.15 M NaCl, centrifuged at 10,000 revolutions
per minute (rpm) for 30 min and filtered.
LDL Fluorescent Labeling
LDL were labeled fluorescently with 1,1´-diocta-
decyl-3,3,3´,3´-tetramethylindocarbocyanine perchlo-
rate (DiI) (Molecular Probes, Eugene, OR) as previously
described [29]. LDL–DiI was dialyzed against 0.15 M
NaCl and 0.01% EDTA as well as PBS to eliminate
EDTA.
Cell Culture
We used Chinese hamster ovary (CHO), SR-
transfected CHO (CHO-SR), and RAW264.7 cells. CHO
and RAW cells were obtained from the American Type
Culture Collection. CHO cells were used as a con-
trol due to the lack of scavenger receptor A (SR-A).
CHO-SR were stably transfected with bovine SR-A
(cells were kindly donated by Dr. Robert E. Pitas,
Gladstone Institute of Cardiovascular Disease, Univer-
sity of California, San Francisco, CA). Cells were cul-
tured in 10% fetal bovine serum–DMEM (Dulbecco´s
modified Eagle´s Media)/F12 containing penicillin
(50 U/mL)/streptomycin (50 μg/mL) for CHO, or ge-
neticin (400 μg/mL) for CHO-SR. RAW cells (murine
monocyte/macrophage) were used to compare SR ac-
tivity in a naturally expressing SR cell line. Cells
were grown in DMEM supplemented with 10% fetal
bovine serum and penicillin (50 U/mL)/streptomycin
(50 μg/mL) at 37◦C in a 5% CO2/95% air atmosphere.
PM-ox-LDL–DiI Binding/Internalization
Assays
LDL–DiI were incubated with 80 μg PM10/mg for
24 h at 37◦C to induce oxidation, centrifuged at 5,000
rpm for 5 min to eliminate PM, and quantified once
again. Confluent cells were incubated for 1 h in serum-
free medium, and then in the presence of PM-ox-LDL–
DiI (2.5, 5, 10, 20, and 40 μg/mL) for 4 h at 4◦C (binding
assay) or 37◦C (internalization assay). Parallel assays
were performed in the presence of 10 times the amount
of nat-LDL and H2O2-ox-LDL to measure nonspecific
binding internalization. Cells were washed five times
with PBS–bovine serum albumin (2 mg/mL), recovered
and analyzed by flow cytometry (FACScalibur instru-
ment, Becton-Dickinson, NJ). To obtain specific bind-
ing/internalization data, fluorescence intensity values
in the presence of an excess of lipoproteins (nat-LDL
and H2O2-ox-LDL) were subtracted from total fluores-
cence intensity values to present final results.
Experiments were carried out using LDL from
three different donors, and results are expressed as rel-
ative units where basal cell fluorescence corresponds to
one relative unit. Relative units were used to normal-
ize for the fluorescence variability observed between
LDL–DiI samples obtained from different donors. Flu-
orescence variability of samples varied from 30 to 70
fluorescence units in the binding assays and between
170 and 280 fluorescence units in internalization assays,
when a dose of 40 μg/mL of PM-ox-LDL-DiI was used
in CHO-SR cells.
PM/LDL Competition Assays
Confluent CHO-SR were exposed to 0, 20, 40, and
80 μg/cm2 of PM2.5 or PM10, and to 20 μg/mL of PM-
ox-LDL-DiI or nat-LDL-DiI for 4 h at 4 or 37◦C. Par-
allel assays were performed using an excess (10 times
the amount) of nat-LDL and H2O2-ox-LDL as indicated
above. Cells were washed, and samples were analyzed
by flow cytometry. RAW cells were only tested using
40 μg/cm2 of PM10 and 20 μg/mL of PM-ox-LDL–DiI
or nat-LDL–DiI.
Cell Viability
Cell viability was assessed in parallel under the
same experimental conditions described above by
trypan-blue exclusion using a Neubauer camera. Try-
pan blue was added to cell suspensions at a final con-
centration of 0.8 mg/mL and incubated for 1 min at
room temperature. The differentiation among the vi-
able and nonviable cells was done through blue cell
coloration under optical microscopy.
PM/LDL Interactions
We also evaluated possible PM–LDL (nat-LDL and
PM-ox-LDL) binding interactions under cell-free condi-
tions, using the same PM and LDL concentrations and
conditions described in the binding/internalization ex-
periments, except for the absence of cells in the assays.
Samples were centrifuged and analyzed by fluorom-
etry. We found that only ∼10% of PM-ox-LDL–DiI or
nat-LDL–DiI total fluorescence was retained by PM.
This indicates that “unspecific” PM binding to LDL in-
troduced an experimental error no larger than 10%.
Statistical Analysis
All experiments were done in triplicate, using
plasma from three independent donors. Graphics were
created to show the average of the three independent
J Biochem Molecular Toxicology DOI 10:1002/jbt
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experiments ± standard deviation (SD). Data were an-
alyzed by one-way analysis of variance (ANOVA) for
competition assays and by factorial ANOVA for ox-
LDL–binding/internalization assays, the last to evalu-
ate the effect of ox-LDL concentration, cell line and the
interaction between both factors (ox-LDL concentra-
tion × cell line). When necessary, variables were trans-
formed to homogenize the variances. Both ANOVA
procedures were followed by multiple comparison
tests (Scheffe test) and specifically for factorial ANOVA,
orthogonal contrasts were performed to determine dif-
ferences between cell lines according to the ox-LDL
concentration. Statistical analysis was performed us-
ing SPSS version 13.0 for Windows. The results were
considered significant when p < 0.05.
RESULTS
LDL exposure to three increasing concentrations
of PM2.5 and PM10 (0, 20, 40, and 80 μg/mg LDL) for
24 h in the absence of H2O2 resulted in a concentration-
related LDL oxidation. Exposures in the presence of
H2O2 resulted in a corresponding increased oxidation
(Figure 1). All further experimentation used PM10 +
H2O2 induced LDL oxidation, due to limited accessi-
bility to PM2.5 samples.
Cell viability evaluation in cells (CHO, CHO-SR,
and RAW) exposed to PM-ox-LDL and/or PM us-
ing the same experimental conditions used for bind-
ing/internalization and competition assays never re-
sulted in viability decrements larger than 10% (data
not shown). Results obtained from each experimental
condition were adjusted according to viability.
PM-ox-LDL–binding/internalization assays in
CHO cells showed a relatively low dose-related basal
activity. In the case of CHO-SR cells, a higher dose-
related PM-ox-LDL binding/internalization was ob-
served (p < 0.05) (Figure 2).
Experimentation was also done using ac-LDL to
investigate whether similar results would be obtained
in our cell system when using traditionally modified
LDL. The ac-LDL yielded similar results to the ones
obtained with PM-ox-LDL using CHO-SR and CHO
cells (data not shown).
PM-ox-LDL–binding/internalization competition
assays in the presence of PM2.5 or PM10 (20, 40, and
80 μg/cm2) resulted in a PM concentration–related de-
creased binding (53%–55% at 80 μg/cm2) (Figures 3A
and 3C) and internalization (73%–78% at 80 μg/cm2)
(p < 0.05) (Figures 3B and 3D).
PM/LDL-R competition binding/internalization
assays performed in CHO-SR cells showed that PM2.5
and PM10 also interfered in a dose-related manner with
nat-LDL binding (62% at 80 μg/cm2) (Figure 4A) and
internalization (86% at 80 μg/cm2) (p < 0.05) (Figure
4B).
When RAW cells binding/internalization assays
were performed, PM-ox-LDL binding was as low
as observed in CHO cells, but internalization was
as high as in CHO-SR cells (p < 0.05). Compe-
tition experiments showed that PM10 (40 μg/cm2)
induced decreased binding/internalization of PM-
ox-LDL (22% and 32%, respectively; p < 0.05).
FIGURE 1. LDL oxidation by PM. LDL were exposed to increasing concentrations of PM2.5 or PM10 (20, 40, and 80 μg/mg LDL) during 24 h at
37◦C with and without H2O2, and LDL oxidation was observed. Thiobarbituric acid reactive substances (TBARS). Mean of three independent
assays ± standard deviation (SD).
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FIGURE 2. PM-ox-LDL binding/internalization by CHO and CHO-SR cells. CHO and CHO-SR cells were incubated with 2.5–40 μg/mL
PM-ox-LDL-DiI for 4 h at 4◦C (binding) or 37◦C (internalization). LDL–DiI were previously oxidized with 80 μg PM10 for 24 h. Cells were
recovered and evaluated by flow cytometry. Mean of three independent assays ± SD. * p < 0.05 vs. similar concentration in CHO cells.
FIGURE 3. Competition of PM-ox-LDL and PM for SR-binding/internalization. Cultures of CHO-SR cells were exposed to 20, 40, and 80
μg/cm2 of PM2.5 (A, B) or PM10 (C, D), and 20μg/mL PM-ox-LDL–DiI for 4 h at 4◦C (A, C) or 37◦C (B, D). Competition assays in the presence of
PM2.5 or PM10 resulted in decreased ox-LDL binding (53%–55%) and internalization (73%–78%) at 80μg/cm2. Mean ± SD of three independent
experiments. * p < 0.05 vs. control.
Binding/internalization decrements were also ob-
served in RAW cells when exposed to PM10 (40μg/cm2)
and nat-LDL (45% and 55%, respectively; p < 0.05) (data
not shown).
DISCUSSION
Evidence suggests that the mechanism by which
PM exerts some of its adverse effects is through
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FIGURE 4. Competition of nat-LDL and PM for LDL-R binding/internalization. CHO-SR cells were exposed to 20, 40, and 80 μg/cm2 of
PM2.5 and 20 μg/mL of native-LDL–DiI for 4 h at 4◦C (A) or 37◦C (B). PM interfered with nat-LDL binding (62%) and internalization (86%) at
80 μg/cm2 with CHO-SR cells. Mean of three independent experiments ± SD. * p < 0.05 vs. control.
oxidative potential [18–21]. Several studies support the
existence of a relation between atherosclerosis and ex-
posure to PM in both humans [13, 14] and animals
[15–17], without fully understanding of the mecha-
nisms involved. Results presented in this paper support
that PM is capable of oxidizing LDL. Both PM fractions,
PM10 and PM2.5, showed similar LDL-oxidative poten-
tials in spite of differences in chemical composition [2].
PM-induced LDL oxidation seems to be mediated by
metallic and nonmetallic PM constituents, since oxida-
tion was induced in the presence/absence of hydrogen
peroxide. Therefore, our experimental data support the
hypothesis that PM could have the potential to aggra-
vate atherosclerosis by promoting the oxidation of LDL
and subsequent uptake by macrophages.
We report that PM is capable of competing for SR
and the LDL-receptor blocking natural ligands bind-
ing. Although it is known that various types of par-
ticles (e.g., diesel, PM1648) [30–33] bind to SR, no
one has previously reported that PM also alters LDL
receptor functionality. This is an indication that PM
could affect cell receptors with potential detrimen-
tal effects on cell function; the most obvious being
the endocytic capacity of macrophages and a con-
sequent altered primary immune response [34, 35].
Since SR is also present in other cell types like en-
dothelial cells [36], it would be interesting to explore
PM interactions with other receptors in various cell
types.
The exact nature of PM/SR interactions and the
mechanisms involved in the observed changes in re-
ceptor functionality remains to be described. These in-
teractions may be related to receptor downregulation
[37], direct physical PM/receptor interaction, or sec-
ondary to PM-related oxidative potential, as described
under different conditions [38–41].
Since in this report we only studied PM-ox-LDL
internalization through the type A scavenger recep-
tor, studies evaluating the participation of other re-
ceptors involved in the atherosclerotic process, such
as macrophage receptor with collagenous structure
(MARCO), type B scavenger receptor, or lectin-type ox-
idized LDL receptor 1 (LOX-1), are still needed [42–44].
In spite of a growing body of research, mecha-
nisms for PM-related cardiovascular effects are still not
completely understood. For instance, we do not know
whether PM can reach the bloodstream and directly af-
fect vascular or cardiac cells, or if the effects observed
in vivo are the result of inflammatory responses taking
place in the respiratory system and then affecting the
cardiovascular system by nervous or chemical media-
tors [45–50]. While it is possible that PM-induced sys-
temic inflammation promotes the oxidation of LDL, our
current study explored LDL oxidation in the event that
PM or some of its compounds could enter the blood-
stream and reach LDL.
In conclusion, we demonstrated that PM can oxi-
dize LDL in a SR recognizable form. Although biologi-
cal and epidemiological evidence relating PM exposure
and atherosclerosis exists, the present work provides
additional mechanistic evidence toward the elucida-
tion of this phenomenon. We also observed that PM is
able to induce changes in cell surface lipid receptors’
functionality. This observation requires more studies
since serious health implications would be related to
these changes.
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